IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.
Köbel M; Xu H; Bourne PA; Spaulding BO; Shih IeM; Mao TL; Soslow RA; Ewanowich CA; Kalloger SE; Mehl E; Lee CH; Huntsman D; Gilks CB; Modern Pathology: An Official Journal Of The United States And Canadian Academy Of Pathology, Inc, 2009, vol. 22, issue 3, p 469, ISSN 15300285. ISBN 15300285.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef